Variable | With HCC (N = 42) | Without HCC | P-value |
---|---|---|---|
Mean age, (SD) | 57.4 (8.4) | 48.6 (11.3) | < 0.0001 |
Median age, IQR | 58 (53,65) | 50 (40,56) | < 0.0001 |
Sex, % male | 45.24% | 49.03% | 0.63 |
Weight, mean (SD) kg | 67.4 (13) | 72.1 (13) | 0.02 |
Obesity (% obese) | 11.90% | 16.93% | 0.40 |
Hypertension, % | 7.14% | 6.93% | 0.96 |
Diabetes, % | 47.60% | 26.90% | 0.004 |
Hepatitis B virus coinfection | 0.30% | 1.06% | 0.09 |
Cirrhosis, % | 100.00% | 45.97% | < 0.0001 |
 Cirrhosis decompensated, % | 30.95% | 9.35% | < 0.0001 |
HCV RNA, median log10 IU/mL (IQR) | 6.30 (5.84,6.51) | 5.87 (5.20,6.45) | 0.24 |
HCV genotype 3 | 95.2 | 90.5 | 0.41 |
Sustained virologic response, % | 87.5 | 92.2 | 0.29 |
Median time to HCC, weeks (IQR) | 28 (21,39) | N/A | – |
Treatment regimen, % | Â | Â | 0.0006 |
 SOF/RBV/PEG-IFN | 2.4 | 26.8 |  |
 SOF/RBV | 71.4 | 61.6 |  |
 SOF/DCV/RBV | 23.8 | 9.7 |  |
 SOF/DCV | 2.4 | 1.9 |  |